Statement Of Financial Position [Abstract]

ABIONYX Pharma - Filing #2813091

Concept As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
Statement of financial position [abstract]
Assets [abstract]
Non-current assets [abstract]
Property, plant and equipment
373,000 EUR
340,000 EUR
Goodwill
5 377 EUR
5 377 EUR
Non-current assets
8 251 EUR
8 821 EUR
Current assets [abstract]
Current inventories
147,000 EUR
177,000 EUR
Cash and cash equivalents
4 046 EUR
7 935 EUR
Current assets
7 572 EUR
13 011 EUR
Assets
15 823 EUR
21 832 EUR
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
1 418 EUR
1 396 EUR
Share premium
8 599 EUR
179 214 EUR
Equity
7 169 EUR
2 726 EUR
192,000 EUR
8 599 EUR
229,000 EUR
1 418 EUR
126,000 EUR
201,000 EUR
169 829 EUR
10 677 EUR
10,000 EUR
179 214 EUR
87,000 EUR
1 396 EUR
5,000 EUR
39,000 EUR
1 232 EUR
6 629 EUR
164 822 EUR
170 322 EUR
136,000 EUR
Liabilities [abstract]
Non-current liabilities [abstract]
Non-current liabilities
3 560 EUR
4 408 EUR
Current liabilities [abstract]
Current provisions [abstract]
Current provisions for employee benefits
417,000 EUR
504,000 EUR
Current provisions
931,000 EUR
942,000 EUR
Trade and other current payables
1 853 EUR
2 705 EUR
Other current financial liabilities
491,000 EUR
653,000 EUR
Other current non-financial liabilities
1 440 EUR
2 046 EUR
Current liabilities
5 094 EUR
6 747 EUR
Equity and liabilities
15 823 EUR
21 832 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.